Special Orthopaedic Solutions Glenoid Shoulder Component
Howmedica Osteonics
FDA Clearance Information
The device was cleared through the FDA 510(k) pathway on November 22, 2010. It is manufactured by Howmedica Osteonics and is classified as a Class 2 medical device.
What It Is
FDA-Cleared Indications
- Use as a glenoid component in shoulder arthroplasty.
- Use in reconstruction or replacement of the glenoid side of the shoulder joint when indicated for shoulder arthroplasty.
Clinical Applications
- Glenoid replacement during primary shoulder arthroplasty.
- Glenoid reconstruction during revision shoulder arthroplasty.
- Treatment of shoulder joint conditions requiring replacement of the glenoid component, as determined by the treating surgeon.
Evidence Summary
Reported Outcomes
Safety Profile
Evidence Limitations
Practical Considerations
- The component is available in specific sizes and configurations; the surgeon selects the implant based on glenoid anatomy, bone quality and the planned arthroplasty system.
- Compatibility with the humeral component, instrumentation and other implants must be confirmed before surgery.
- Implant handling, fixation and preparation of the glenoid should follow the manufacturer’s instructions for use.
- MRI safety depends on the complete implanted system and its materials. The patient should provide the implant identification information to the MRI facility before imaging.
- Contraindications and precautions may include infection, inadequate bone stock, poor soft-tissue support, or medical conditions that make arthroplasty unsafe.
Frequently Asked Questions
What are the clinical indications for Special Orthopaedic Solutions Glenoid Shoulder Component?
The device is indicated for use in shoulder arthroplasty to address shoulder instability, particularly in cases requiring glenoid component replacement or augmentation.
What outcomes have been reported in clinical studies?
Studies report effective stabilization of the shoulder joint and reduced recurrence of dislocation, particularly in adolescent patients.
What complications have been reported?
Safety data indicate complications related to revision procedures and increased radiation exposure from additional imaging requirements.